SinoMab BioScience Limited

HK$1.00As of Sun 8 Nov 2026, 12:00 UTC
HKEX:3681Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR (18.90%)
Div yield —
ROE (60.37%)
Biotechnology
Beta (5Y) 0.69
PE TTM —
TSR TTM (38.65%)
Mkt cap HK$1.387B
ROIC (15.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.962
(3.84%)
(74.14%)
Hold 7|4|2|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.01
0.01
0.01
15.86%
25.51%
21.91%
17.95%
Revenue¥M
61.24
62.14
60.74
61.01
3.13%
4.77%
0.46%
0.33%
Peers (US$176.9M)
Cap (US$)
PE
176.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.388
0.264
0.229
EBIT/Intx
3.034
0.128
0.146
Own earn%
75.79
83.06
86.24
Sh yield%
22.06
39.05
39.02
Owners
Insiders/Inst%
7.97
54.25
Short interest%
3.18
SBC / revenue%
1.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
3